Bacampicillin: Difference between revisions
m Protected "Bacampicillin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
||
| Line 29: | Line 29: | ||
{{SI}} | {{SI}} | ||
'''Bacampicillin''' ([[International Nonproprietary Name|INN]]) is a [[penicillin]] [[antibiotic]]. It is a [[prodrug]] of [[ampicillin]] with improved oral [[bioavailability]].<ref>{{cite journal |author=Bodin NO, Ekström B, Forsgren U, ''et al'' |title=Bacampicillin: a new orally well-absorbed derivative of ampicillin |journal=Antimicrob Agents Chemother |volume=8 |issue=5 |pages=518–25 |year=1975 |month=November |pmid=1211909 |doi= |url=http://aac.asm.org/cgi/pmidlookup?view=long&pmid=1211909}}</ref> | '''Bacampicillin''' ([[International Nonproprietary Name|INN]]) is a [[penicillin]] [[antibiotic]]. It is a [[prodrug]] of [[ampicillin]] with improved oral [[bioavailability]].<ref>{{cite journal |author=Bodin NO, Ekström B, Forsgren U, ''et al'' |title=Bacampicillin: a new orally well-absorbed derivative of ampicillin |journal=Antimicrob Agents Chemother |volume=8 |issue=5 |pages=518–25 |year=1975 |month=November |pmid=1211909 |doi= |url=http://aac.asm.org/cgi/pmidlookup?view=long&pmid=1211909}}</ref> | ||
| Line 41: | Line 41: | ||
{{PenicillinAntiBiotics}} | {{PenicillinAntiBiotics}} | ||
[[Category:Beta-lactam antibiotics]] | [[Category:Beta-lactam antibiotics]] | ||
Latest revision as of 22:42, 8 August 2012
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code | |
| Pharmacokinetic data | |
| Metabolism | Rapidly hydrolyzed to ampicillin |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C21H27N3O7S |
| Molar mass | 465.519 g/mol |
|
WikiDoc Resources for Bacampicillin |
|
Articles |
|---|
|
Most recent articles on Bacampicillin Most cited articles on Bacampicillin |
|
Media |
|
Powerpoint slides on Bacampicillin |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Bacampicillin at Clinical Trials.gov Trial results on Bacampicillin Clinical Trials on Bacampicillin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Bacampicillin NICE Guidance on Bacampicillin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Bacampicillin Discussion groups on Bacampicillin Patient Handouts on Bacampicillin Directions to Hospitals Treating Bacampicillin Risk calculators and risk factors for Bacampicillin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Bacampicillin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Bacampicillin (INN) is a penicillin antibiotic. It is a prodrug of ampicillin with improved oral bioavailability.[1]
It is sold under the brand names Spectrobid (Pfizer) and Penglobe (AstraZeneca).
References
- ↑ Bodin NO, Ekström B, Forsgren U; et al. (1975). "Bacampicillin: a new orally well-absorbed derivative of ampicillin". Antimicrob Agents Chemother. 8 (5): 518–25. PMID 1211909. Unknown parameter
|month=ignored (help)
- Pages with script errors
- Pages with citations using unsupported parameters
- CS1 maint: Explicit use of et al.
- CS1 maint: Multiple names: authors list
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Beta-lactam antibiotics
- Carboxylate esters
- Prodrugs